The Congressional Budget Office (CBO) estimates the Protecting Patients Against PBM Abuses Act, a bill the House Energy & Commerce Committee passed in December that aims to delink the compensation pharmacy benefit managers receive from drug makers from prescription drug list prices, would result in a $226 million decrease in the deficit over 10 years, according to cost estimates for several E&C bills published Wednesday (March 13). A separate PBM transparency bill advanced by the committee in December would save...